metformin has been researched along with stattic in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bogdahn, U; Hau, P; Leidgens, V; Moeckel, S; Proescholdt, M; Proske, J; Rauer, L; Renner, K; Riemenschneider, MJ; Seliger, C; Vollmann-Zwerenz, A | 1 |
1 other study(ies) available for metformin and stattic
Article | Year |
---|---|
Stattic and metformin inhibit brain tumor initiating cells by reducing STAT3-phosphorylation.
Topics: Adult; Aged; AMP-Activated Protein Kinases; Animals; Antineoplastic Combined Chemotherapy Protocols; Brain Neoplasms; Carrier Proteins; Cell Line, Tumor; Cell Movement; Cell Proliferation; Cyclic S-Oxides; Dose-Response Relationship, Drug; Female; Gene Expression Regulation, Neoplastic; Glioblastoma; Humans; Male; Metformin; Middle Aged; Neoplasm Metastasis; Neoplastic Stem Cells; Phosphorylation; Rats, Long-Evans; Rats, Sprague-Dawley; Rats, Wistar; RNA Interference; RNA-Binding Proteins; Signal Transduction; STAT3 Transcription Factor; Time Factors; Transfection; Tumor Cells, Cultured | 2017 |